Formulation and Evaluation of Gastro Retentive Drug Delivery System for Ofloxacin

DOI:

https://doi.org/10.37285/ijpsn.2009.2.1.6

Authors

  • Dumpeti Janardhan
  • Sreekanth Joginapally
  • Bharat V.
  • Rama Subramaniyan P.

Abstract

The purpose of this investigation was to prepare a gastroretentive drug delivery system of Ofloxacin. Ofloxacin is a fluoroquinolone antibacterial which acts by inhibiting the topoisomerase enzyme which is essential in the reproduction of the bacterial DNA. It is highly soluble in acidic media and precipitates in alkaline media thereby losing its solubility. Hence, a gastroretentive system was developed to enhance the bioavailability by retaining it in the acidic environment of the stomach. Different formulations were formulated using various concentrations of hydroxy propyl methyl cellulose, sodium carboxy methyl cellulose, sodium bicarbonate and citric acid. The formulations were evaluated for quality control tests and all the physical parameters evaluated are within the acceptable limits of Indian Pharmacopoeia. All the formulations were subjected to in-vitro dissolution studies and compared with the marketed formulation. The floating lag time was below 15 seconds for all the formulations except F1 and F2. The floating duration was found to be more than 24 hours in all except F1, F2 and F10. Formulations F7 and F8 were used to study the effect of sodium bicarbonate and formulations F9 and F10 for the effect of hardness on the drug release. Drug release kinetics was studied for prepared formulations and optimized formulation F5 was found to follow zero order kinetics with r2 =0.993. The statistical analysis of the parameters of dissolution data obtained before and after storage for 3 months at 25°C/ 60%RH and 40°C/75%RH showed no significant change indicating the two dissolution profiles were similar.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Ofloxacin, gastroretentive, floating tablets, controlled release

Downloads

Published

2009-05-31

How to Cite

1.
Janardhan D, Joginapally S, V. B, P. RS. Formulation and Evaluation of Gastro Retentive Drug Delivery System for Ofloxacin. Scopus Indexed [Internet]. 2009 May 31 [cited 2024 May 19];2(1):428-34. Available from: http://www.ijpsnonline.com/index.php/ijpsn/article/view/284

Issue

Section

Research Articles

References

B. R. Mathews, Regulatory aspects of stability testing in Europe, Drug Dev. Ind. Pharm. 25: 831–856 (1999).
M. Chavanpatil, P. Jain, S. Chaudari, R. Shear and P. Vavia, Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation, Int. J. Pharm. 304: 178-184 (2005).
M.D. Chavanpatil, P. Jain, S. Chaudari, R. Shear and P.R Vavia, Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin, Int. J. Pharm. 316: 86-92 (2006).
M.D. Chavanpatil, P. Jain, S. Chaudari, R. Shear and P.R Vavia, Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin, Int. J. Pharm. 316: 86-92 (2006).
M.N. Gambhire, K.W. Ambade, S.D. Kurmi, V.J. Kadam and K.R. Jadhav, Development and In Vitro Evaluation of an Oral Floating Matrix Tablet Formulation of Diltiazem Hydrochloride, AAPS PharmSciTech 8(3) : E1-E9 (2007).
Rosa M, Zia H, Rhodes T. Dosing and testing in-vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm. 105: 65-70 (1994).
S.S. Patel, S. Ray and R.S. Thakur, Formulation and evaluation of floating drug delivery system containing Clarithromycin for Helicobacter pylori, Acta Pol. Pharm. Drug Res. 63(1) : 53-61 (2006).